Biological therapies for spondyloarthritis. - Wikidata - awgldk - TriplyDB

Biological therapies for spondyloarthritis.

Biological therapies for spondyloarthritis.

http://www.wikidata.org/entity/Q38217223

about

Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies Management of arthropathy in inflammatory bowel diseases.Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis.Medical Treatment of Ankylosing Spondylitis Pharmacological therapy of spondyloarthritis.

P2860

Q26777084-1DD148E7-8923-46A2-BD16-9645A0851653 Q35091366-D29E379E-703E-426A-9D20-269BBE57A46A Q35758262-F7F45FC2-9624-4DF3-93C9-517AC112AD57 Q37147133-64A21807-778F-40DC-8F1E-562875B99A69 Q38527552-191DE7AA-D669-42DB-9B22-B5C404CC3DC1

P2860

Biological therapies for spondyloarthritis.

http://www.wikidata.org/entity/Q38217223

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Biological therapies for spondyloarthritis.

@en

type

label

Biological therapies for spondyloarthritis.

@en

prefLabel

Biological therapies for spondyloarthritis.

@en

P1433

Q38217223-ECCCA2C4-B8BA-4195-90BD-BFA1F96938D3

P1476

Q38217223-AAB35B91-BA60-44DA-B517-5611F5A1550D

P2093

Q38217223-0208425F-F779-4FD6-B93F-90EC45E5EBB8

Q38217223-6DB37C8C-3B09-4F01-B8DD-76C8FB22A088

Q38217223-C80E5BAF-1A67-484D-A092-2D8B78F46A29

Q38217223-E9D41A89-33B0-44D9-AA13-5651C58F0C2D

P2860

Q38217223-01E77E67-218D-471E-AF64-3680DA4FCECA

Q38217223-028FDA70-054A-4BFD-8E12-B0275DD05EFF

Q38217223-05C841C3-AD84-4DDE-859B-4C3802EDB2CD

Q38217223-116C807C-6470-4900-8D4C-1E3A50722C95

Q38217223-123EC245-9824-4E02-BBBA-536D8510D1CF

Q38217223-12934866-BF38-492D-A95E-1DD6F91A3DED

Q38217223-13413BAB-214B-4402-BB7C-22FBC32CE7A2

Q38217223-174F0A40-628D-4033-96C5-79239F0EF658

Q38217223-2A1A3EED-5A4A-4CC2-AB08-F60EAA797AE6

Q38217223-2DFB833E-0136-433F-8C7F-69385238E6D3

P304

Q38217223-60369182-2E84-4894-9F4B-49427FE8E89A

P31

Q38217223-0A63EA33-F026-44FC-A07D-32E13EFF1C59

P356

Q38217223-7469CD51-36DC-4A05-9306-E44899C90F2F

P433

Q38217223-9E3EFD21-55A7-4025-99BB-4B0F9BEA2468

P478

Q38217223-006DAB82-DF71-450F-8248-DA1E414A3285

P50

Q38217223-C66EDA57-66A1-4AB3-A127-87BCBE1DF6C1

P577

Q38217223-1697BCF4-D78D-4336-A4F7-9F99CCC0FE87

P698

Q38217223-8663B66A-617E-4676-B0DF-78A426173F8C

P932

Q38217223-4A6DBA97-F4CF-486B-824B-4FBDDED38CF5

P356

1759720X14535512

P1433

Therapeutic advances in musculoskeletal disease

P1476

Biological therapies for spondyloarthritis.

@en

P2093

Angelo Spanò

http://www.w3.org/2001/XMLSchema#string

Mariangela Atteno

http://www.w3.org/2001/XMLSchema#string

Rosario Peluso

http://www.w3.org/2001/XMLSchema#string

Vincenzo Bruner

http://www.w3.org/2001/XMLSchema#string

P2860

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Infliximab for induction and maintenance therapy for ulcerative colitis

Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs.

Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years.

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology.

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Spondyloarthritides: evolving therapies

P304

92-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1759720X14535512

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Raffaele Scarpa

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24891880

http://www.w3.org/2001/XMLSchema#string

P932

4040940

http://www.w3.org/2001/XMLSchema#string